Kistemann Thomas, Hüneburg Hilmar, Exner Martin, Vacata Vladimir, Engelhart Steffen
Institute of Hygiene and Public Health, University of Bonn, Sigmund-Freud-Str. 25, D-53105 Bonn, Germany.
Int J Hyg Environ Health. 2002 Feb;204(5-6):347-51. doi: 10.1078/1438-4639-00106.
We report about a 75-year-old woman and a 62-year-old man hospitalised for infection-related exacerbation of chronic obstructive pulmonary disease (COPD). In both patients, respiratory function worsened after initial stabilisation and the disease took a fatal course. A careful inspection of the intensive care unit (ICU) revealed several circumstances known to be risk factors for invasive aspergillosis (reconstruction activities near to the ICU, contamination of the window sills with pigeon droppings, moist building materials due to water leakage). The case reports suggest that both critically ill patients receiving high dose corticosteroid medication possibly have acquired aspergillosis on account of increased environmental exposure to Aspergillus conidia (> 10(2) CFU/m3 air). However, due to the severity of the disease confirmation by invasive diagnostic procedures was not possible. The role of high dose corticosteroid treatment as a risk factor for invasive aspergillosis should be taken into consideration, and increased exposure to fungi consequently be reduced in health care environments, especially for patients at risk.
我们报告了一名75岁女性和一名62岁男性,他们因慢性阻塞性肺疾病(COPD)感染相关加重而住院。在这两名患者中,呼吸功能在初始稳定后恶化,疾病呈致命病程。对重症监护病房(ICU)进行仔细检查发现了几种已知的侵袭性曲霉病危险因素(ICU附近的重建活动、窗台被鸽粪污染、因漏水导致建筑材料潮湿)。病例报告表明,这两名接受高剂量皮质类固醇药物治疗的重症患者可能由于环境中曲霉分生孢子暴露增加(>10²CFU/m³空气)而感染了曲霉病。然而,由于疾病的严重性,无法通过侵入性诊断程序进行确诊。应考虑高剂量皮质类固醇治疗作为侵袭性曲霉病危险因素的作用,并因此减少医疗环境中尤其是高危患者对真菌的暴露增加。